Targeted Alpha Therapy: Navigating the Path to Clinical Implementation and Future Outlook

Webinar on-demand with Prof Dr Frederik Giesel and Prof Dr Hugo Levillain

Targeted Alpha Therapy: Navigating the Path to Clinical Implementation and Future Outlook

Prof Dr Frederik Giesel, University Hospital of Dusseldorf & Prof Dr Hugo Levillain, University Hospital of Brussels

• Latest advancements in radiopharmaceutical development
• Key clinical trials involving Actinium-225
• Early and upcoming trials with Astatine-211: the challenges & future directions

Are you interested in watching the next webinars with live Q&A sessions? Subscribe to our newsletter below.

 

 

• 

  The New Era of Alpha Emitters in the Translation to Clinical Arena

  Prof Dr Frederik Giesel

  Chairman of Nuclear Medicine Department, University Hospital Düsseldorf (UKD), Germany Visiting Professor at the Osaka University, Japan

• 

  Accelerate.EU, a European initiative: The INSPIRE Study on Astatine-211 Theranostics for Triple-Negative Breast Cancer

  Prof Dr Hugo Levillain

  Medical Physicist - Head of R&D Medical Physics Department University Hospital Brussels Co-director of the Radiophysics and MRI physics laboratory Faculty of Medicine ULB Director of NuMix Center of Microscopy and Molecular Imaging (CMMI) Gosselies ULB